By NanoBrand
Silver nanoparticles (AgNPs) are being investigated for wound dressings, hydrogels, foams, films, fibres, and textiles to provide local antimicrobial activity at the wound interface. AgNPs-containing dressings may help manage microbial burden and bacterial colonisation in chronic wounds, burns, diabetic foot ulcers, venous leg ulcers, pressure injuries, and other wounds at risk of infection. Performance depends on AgNP size, concentration, surface chemistry, dispersion, silver-release profile, and compatibility with the finished dressing. Development should assess antimicrobial activity, biocompatibility, cytotoxicity, silver release, durability, moisture management, and stability under intended-use conditions. Clinical evidence for silver-containing dressings varies by wound type and endpoint; they are generally most relevant for microbial burden or infected wounds. NanoBrand supports AgNP selection and early-stage antimicrobial wound-dressing research, including particle-size selection, surface stabilization, and incorporation into hydrogel, polymer, fibre, and textile matrices.
